Welch Allyn to acquire HealthInterlink in telemonitoring move
December 17, 2014
Medical diagnostic device player Welch Allyn has announced a takeover of telehealth company HealthInterlink.
Welch Allyn (Skaneateles Falls, NY, USA) did not disclose financial details of the transaction but said HealthInterlink (Omaha, NE, USA) had developed a remote patient monitoring service that has already been cleared for marketing in the US.
The technology incorporates wireless patient monitoring devices as well as a mobile gateway device – such as a tablet or smartphone – that can transmit vital-signs data to a cloud-based system, from where it can be accessed by healthcare professionals and other authorized stakeholders.
Stephen Meyer, the president and chief executive of Welch Allyn, says the acquisition of the HealthInterlink assets will allow Welch Allyn to better serve its US customers.
“The acquisition of HealthInterlink’s assets is exciting news for Welch Allyn and is in keeping with our vision to help transform care wherever patients and healthcare professionals connect,” he said. “As healthcare delivery becomes decentralized and extends beyond the traditional acute and ambulatory care locations where our offerings are used today, we intend to provide solutions that enable providers to deliver high quality care, regardless of location.”
HealthInterlink’s product will continue to be developed, sourced and sold by the company’s existing workforce during a transition period, according to Welch Allyn, adding it will be “business as usual” while the integration is underway.
“As an innovative medical software company specializing in remote patient vital signs monitoring, we believe that joining Welch Allyn will accelerate adoption of a practical telehealth solution designed to provide better outcomes and value for patients and providers alike,” said Danna Kehm, HealthInterlink’s managing director. “HealthInterlink’s software and telehealth expertise coupled with Welch Allyn’s sales, marketing and customer support strength will give clinicians a powerful tool to manage more patients outside traditional healthcare settings.”
Both companies say that remote patient monitoring could provide a solution for managing the rise and growing cost of chronic diseases.
“This acquisition will enable us to help clinicians prioritize patient care, allowing for early intervention and facilitating communication with patients outside traditional healthcare settings,” said Meyer. “Furthermore, we believe that this represents an exciting opportunity to advance the trend of investing in non-hospitalized and post-acute care monitoring to help take cost out of the system and help patients adhere to treatment plans – in the doctor’s office and beyond.”